Psoriasis Drugs Market Segmented By Topical Psoriasis Drug, Oral Psoriasis Drug and Injectable Psoriasis Drug Product with Corticosteroids, Anti-inflammatory, Interleukin Inhibitors, and Tumor Necrosis Factor Inhibitors Drug Class, with Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis, and Erythrodermic psoriasis Disease Indication
Industry: Healthcare
Published Date: February-2022
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 243
Report ID: PMRREP25102
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Market Background
4.1. Macro-Economic Factors
4.1.1. Global GDP Growth Outlook
4.1.2. Global Pharmaceuticals Outlook
4.1.3. Global Ageing Population Outlook
4.2. Forecast Factors - Relevance & Impact
4.2.1. Increasing Burden of Disease
4.2.2. Increasing healthcare spending per capita
4.2.3. Historic growth of manufactures
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity Analysis
5. COVID19 Crisis Analysis
5.1. Current COVID19 Statistics and Probable Future Impact
5.2. Current GDP Projection and Probable Impact
5.3. Current Economic Projection as compared to 2008 financial analysis
5.4. COVID19 and Impact Analysis
5.4.1. Revenue By Product
5.4.2. Revenue By Drug Class
5.4.3. Revenue By Distribution Channel
5.4.4. Revenue By Indication
5.4.5. Revenue By Country
5.5. 2022 Market Scenario
6. Key Success Factors
6.1. Recent Development/ Approvals
6.2. Strategic Promotional Strategies
6.3. Supply Chain Analysis
6.4. Porter’s Five Forces Analysis
6.5. Regulatory Dynamics
6.6. Disease Epidemiology
7. Global Psoriasis Drugs Market Demand (Size in US$ Mn) Analysis 2016-2021 and Forecast, 2022-2031
7.1. Historical Market Value (US$ Mn) Analysis, 2016-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2031
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Psoriasis Drugs Market Analysis 2016-2021 and Forecast 2022-2031, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (In Value or Size in US$ Mn) Trend By Product, 2016-2021
8.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis and Forecast By Product, 2022-2031
8.3.1. Topical
8.3.2. Oral
8.3.3. Injectable
8.4. Market Attractiveness Analysis By Product
9. Global Psoriasis Drugs Market Analysis 2016-2021 and Forecast 2022-2031, By Drug Class
9.1. Introduction / Key Findings
9.2. Historical Market Size (In Value or Size in US$ Mn) Trend By Drug Class, 2016-2021
9.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis and Forecast By Drug Class, 2022-2031
9.3.1. Interleukin Inhibitors
9.3.2. Corticosteroids
9.3.3. Anti-inflammatory
9.3.4. Tumor Necrosis Factor Inhibitor
9.4. Market Attractiveness Analysis By Drug Class
10. Global Psoriasis Drugs Market Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel
10.1. Introduction / Key Findings
10.2. Historical Market Size (In Value or Size in US$ Mn) Trend By Distribution Channel, 2016-2021
10.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis and Forecast By Distribution Channel, 2022-2031
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. E-Commerce
10.4. Market Attractiveness Analysis By Distribution Channel
11. Global Psoriasis Drugs Market Analysis 2016-2021 and Forecast 2022-2031, By Indication
11.1. Introduction / Key Findings
11.2. Historical Market Size (In Value or Size in US$ Mn) Trend By Indication, 2016-2021
11.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis and Forecast By Indication , 2022-2031
11.3.1. Guttate Psoriasis
11.3.2. Inverse Psoriasis
11.3.3. Pustular Psoriasis
11.3.4. Erythrodermic Psoriasis
11.3.5. Plaque Psoriasis
11.4. Market Attractiveness Analysis By Indication
12. Global Psoriasis Drugs Market Analysis 2016-2021 and Forecast 2022-2031, by Region
12.1. Introduction
12.2. Historical Market Size (In Value or Size in US$ Mn) Analysis By Region, 2016 - 2021
12.3. Current Market Size (In Value or Size in US$ Mn) Analysis and Forecast By Region, 2022 - 2031
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. South Asia
12.3.5. East Asia
12.3.6. Oceania
12.3.7. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Psoriasis Drugs Market Analysis 2016-2021 and Forecast 2022-2031
13.1. Introduction
13.2. Historical Market Size (In Value or Size in US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
13.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis Forecast By Market Taxonomy, 2022-2031
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Product
13.3.3. By Drug Class
13.3.4. By Distribution Channel
13.3.5. By Indication
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. Latin America Psoriasis Drugs Market Analysis 2016-2021 and Forecast 2022-2031
14.1. Introduction
14.2. Historical Market Size (In Value or Size in US$ Mn) Trend Analysis By Market Taxonomy, 2016 - 2021
14.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis Forecast By Market Taxonomy, 2022-2031
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Rest of Latin America
14.3.2. By Product
14.3.3. By Drug Class
14.3.4. By Distribution Channel
14.3.5. By Indication
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. Europe Psoriasis Drugs Market Analysis 2016-2021 and Forecast 2022-2031
15.1. Introduction
15.2. Historical Market Size (In Value or Size in US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
15.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis Forecast By Market Taxonomy 2022-2031
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. Russia
15.3.1.7. BENELUX
15.3.1.8. Rest of Europe
15.3.2. By Product
15.3.3. By Drug Class
15.3.4. By Distribution Channel
15.3.5. By Indication
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. South Asia Psoriasis Drugs Market Analysis 2016-2021 and Forecast 2022-2031
16.1. Introduction
16.2. Historical Market Size (In Value or Size in US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
16.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis Forecast By Market Taxonomy 2022-2031
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Indonesia
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Product
16.3.3. By Drug Class
16.3.4. By Distribution Channel
16.3.5. By Indication
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. East Asia Psoriasis Drugs Market Analysis 2016-2021 and Forecast 2022-2031
17.1. Introduction
17.2. Historical Market Size (In Value or Size in US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
17.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis By Market Taxonomy 2022-2031
17.3.1. By Country
17.3.1.1. Japan
17.3.1.2. China
17.3.1.3. South Korea
17.3.2. By Product
17.3.3. By Drug Class
17.3.4. By Distribution Channel
17.3.5. By Indication
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. Oceania Psoriasis Drugs Market Analysis 2016-2021 and Forecast 2022-2031
18.1. Introduction
18.2. Historical Market Size (In Value or Size in US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
18.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis By Market Taxonomy 2022-2031
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product
18.3.3. By Drug Class
18.3.4. By Distribution Channel
18.3.5. By Indication
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Middle East and Africa Psoriasis Drugs Market Analysis 2016-2021 and Forecast 2022-2031
19.1. Introduction
19.2. Historical Market Size (In Value or Size in US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
19.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis By Market Taxonomy, 2022-2031
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. South Africa
19.3.1.3. Rest of Middle East and Africa
19.3.2. By Product
19.3.3. By Drug Class
19.3.4. By Distribution Channel
19.3.5. By Indication
19.4. Market Attractiveness Analysis
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
20. Countries Psoriasis Drugs Market Analysis 2022 & 2031
20.1. Introduction
20.1.1. Market Value Proportion Analysis, By Key Countries
20.1.2. Global Vs. Country Growth Comparison
20.2. U.S. Psoriasis Drugs Market Value (US$) Analysis, 2022 & 2031
20.2.1. By Product
20.2.2. By Drug Class
20.2.3. By Distribution Channel
20.2.4. By Indication
20.3. Canada Psoriasis Drugs Market Value (US$) Analysis, 2022 & 2031
20.3.1. By Product
20.3.2. By Drug Class
20.3.3. By Distribution Channel
20.3.4. By Indication
20.4. Brazil Psoriasis Drugs Market Value (US$) Analysis, 2022 & 2031
20.4.1. By Product
20.4.2. By Drug Class
20.4.3. By Distribution Channel
20.4.4. By Indication
20.5. Mexico Psoriasis Drugs Market Value (US$) Analysis, 2022 & 2031
20.5.1. By Product
20.5.2. By Drug Class
20.5.3. By Distribution Channel
20.5.4. By Indication
20.6. U.K. Psoriasis Drugs Market Value (US$) Analysis, 2022 & 2031
20.6.1. By Product
20.6.2. By Drug Class
20.6.3. By Distribution Channel
20.6.4. By Indication
20.7. Germany Psoriasis Drugs Market Value (US$) Analysis, 2022 & 2031
20.7.1. By Product
20.7.2. By Drug Class
20.7.3. By Distribution Channel
20.7.4. By Indication
20.8. France Psoriasis Drugs Market Value (US$) Analysis, 2022 & 2031
20.8.1. By Product
20.8.2. By Drug Class
20.8.3. By Distribution Channel
20.8.4. By Indication
20.9. Italy Psoriasis Drugs Market Value (US$) Analysis, 2022 & 2031
20.9.1. By Product
20.9.2. By Drug Class
20.9.3. By Distribution Channel
20.9.4. By Indication
20.10. Spain Psoriasis Drugs Market Value (US$) Analysis, 2022 & 2031
20.10.1. By Product
20.10.2. By Drug Class
20.10.3. By Distribution Channel
20.10.4. By Indication
20.11. BENELUX Psoriasis Drugs Market Value (US$) Analysis, 2022 & 2031
20.11.1. By Product
20.11.2. By Drug Class
20.11.3. By Distribution Channel
20.11.4. By Indication
20.12. Russia Psoriasis Drugs Market Value (US$) Analysis, 2022 & 2031
20.12.1. By Product
20.12.2. By Drug Class
20.12.3. By Distribution Channel
20.12.4. By Indication
20.13. India Psoriasis Drugs Market Value (US$) Analysis, 2022 & 2031
20.13.1. By Product
20.13.2. By Drug Class
20.13.3. By Distribution Channel
20.13.4. By Indication
20.14. Thailand Psoriasis Drugs Market Value (US$) Analysis, 2022 & 2031
20.14.1. By Product
20.14.2. By Drug Class
20.14.3. By Distribution Channel
20.14.4. By Indication
20.15. Indonesia Psoriasis Drugs Market Value (US$) Analysis, 2022 & 2031
20.15.1. By Product
20.15.2. By Drug Class
20.15.3. By Distribution Channel
20.15.4. By Indication
20.16. Malaysia Psoriasis Drugs Market Value (US$) Analysis, 2022 & 2031
20.16.1. By Product
20.16.2. By Drug Class
20.16.3. By Distribution Channel
20.16.4. By Indication
20.17. China Psoriasis Drugs Market Value (US$) Analysis, 2022 & 2031
20.17.1. By Product
20.17.2. By Drug Class
20.17.3. By Distribution Channel
20.17.4. By Indication
20.18. South Korea Psoriasis Drugs Market Value (US$) Analysis, 2022 & 2031
20.18.1. By Product
20.18.2. By Drug Class
20.18.3. By Distribution Channel
20.18.4. By Indication
20.19. Japan Psoriasis Drugs Market Value (US$) Analysis, 2022 & 2031
20.19.1. By Product
20.19.2. By Drug Class
20.19.3. By Distribution Channel
20.19.4. By Indication
20.20. Australia Psoriasis Drugs Market Value (US$) Analysis, 2022 & 2031
20.20.1. By Product
20.20.2. By Drug Class
20.20.3. By Distribution Channel
20.20.4. By Indication
20.21. New Zealand Psoriasis Drugs Market Value (US$) Analysis, 2022 & 2031
20.21.1. By Product
20.21.2. By Drug Class
20.21.3. By Distribution Channel
20.21.4. By Indication
20.22. GCC Countries Psoriasis Drugs Market Value (US$) Analysis, 2022 & 2031
20.22.1. By Product
20.22.2. By Drug Class
20.22.3. By Distribution Channel
20.22.4. By Indication
20.23. South Africa Psoriasis Drugs Market Value (US$) and Analysis, 2022 & 2031
20.23.1. By Product
20.23.2. By Drug Class
20.23.3. By Distribution Channel
20.23.4. By Indication
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Concentration
21.3. Market Share Analysis of Top Players
21.4. Market Presence Analysis
21.4.1. Regional footprint of Players
21.4.2. Method foot print by Players
21.4.3. Channel Foot Print by Players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Janssen Biotech, Inc.
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Profitability by Market Segments (Product/Indication/Region)
22.3.1.4. Sales Footprint
22.3.1.5. Strategy Overview
22.3.1.5.1. Marketing Strategy
22.3.1.5.2. Product Strategy
22.3.1.5.3. Indication Strategy
22.3.2. Novartis International Ltd.
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Profitability by Market Segments (Product/Indication/Region)
22.3.2.4. Sales Footprint
22.3.2.5. Strategy Overview
22.3.2.5.1. Marketing Strategy
22.3.2.5.2. Product Strategy
22.3.2.5.3. Indication Strategy
22.3.3. Amgen Inc
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Profitability by Market Segments (Product/Indication/Region)
22.3.3.4. Sales Footprint
22.3.3.5. Strategy Overview
22.3.3.5.1. Marketing Strategy
22.3.3.5.2. Product Strategy
22.3.3.5.3. Indication Strategy
22.3.4. Pfizer Inc.
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Profitability by Market Segments (Product/Indication/Region)
22.3.4.4. Sales Footprint
22.3.4.5. Strategy Overview
22.3.4.5.1. Marketing Strategy
22.3.4.5.2. Product Strategy
22.3.4.5.3. Indication Strategy
22.3.5. Takeda Pharmaceutical Company Ltd.
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Profitability by Market Segments (Product/Indication/Region)
22.3.5.4. Sales Footprint
22.3.5.5. Strategy Overview
22.3.5.5.1. Marketing Strategy
22.3.5.5.2. Product Strategy
22.3.5.5.3. Indication Strategy
22.3.6. Merck & Co, Inc.
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Profitability by Market Segments (Product/Indication/Region)
22.3.6.4. Sales Footprint
22.3.6.5. Strategy Overview
22.3.6.5.1. Marketing Strategy
22.3.6.5.2. Product Strategy
22.3.6.5.3. Indication Strategy
22.3.7. Abb Vie Inc.
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Profitability by Market Segments (Product/Indication/Region)
22.3.7.4. Sales Footprint
22.3.7.5. Strategy Overview
22.3.7.5.1. Marketing Strategy
22.3.7.5.2. Product Strategy
22.3.7.5.3. Indication Strategy
22.3.8. Eli Lilly and Company
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Profitability by Market Segments (Product/Indication/Region)
22.3.8.4. Sales Footprint
22.3.8.5. Strategy Overview
22.3.8.5.1. Marketing Strategy
22.3.8.5.2. Product Strategy
22.3.8.5.3. Indication Strategy
22.3.9. Boehringer Ingelheim GmbH
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Profitability by Market Segments (Product/Indication/Region)
22.3.9.4. Sales Footprint
22.3.9.5. Strategy Overview
22.3.9.5.1. Marketing Strategy
22.3.9.5.2. Product Strategy
22.3.9.5.3. Indication Strategy
22.3.10. Sun Pharmaceutical Industries Ltd
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Profitability by Market Segments (Product/Indication/Region)
22.3.10.4. Sales Footprint
22.3.10.5. Strategy Overview
22.3.10.5.1. Marketing Strategy
22.3.10.5.2. Product Strategy
22.3.10.5.3. Indication Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Table 1: Global Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Product
Table 2: Global Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Drug Class
Table 3: Global Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel
Table 4: Global Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Indication
Table 5: Global Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Region
Table 6: North America Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Product
Table 7: North America Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Drug Class
Table 8: North America Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel
Table 9: North America Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Indication
Table 10: North America Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Country
Table 11: Latin America Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Product
Table 12: Latin America Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Drug Class
Table 13: Latin America Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel
Table 14: Latin America Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Indication
Table 15: Latin America Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Country
Table 16: Europe Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Product
Table 17: Europe Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Drug Class
Table 18: Europe Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel
Table 19: Europe Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Indication
Table 20: Europe Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Country
Table 21: East Asia Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Product
Table 22: East Asia Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Drug Class
Table 23: East Asia Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel
Table 24: East Asia Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Indication
Table 25: East Asia Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Country
Table 26: South Asia Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Product
Table 27: South Asia Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Drug Class
Table 28: South Asia Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel
Table 29: South Asia Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Indication
Table 30: South Asia Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Country
Table 31: Oceania Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Product
Table 32: Oceania Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Drug Class
Table 33: Oceania Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel
Table 34: Oceania Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Indication
Table 35: Oceania Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Country
Table 36: MEA Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Product
Table 37: MEA Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Drug Class
Table 38: MEA Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel
Table 39: MEA Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Indication
Table 40: MEA Psoriasis Drugs Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Country
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
Figure 1: Global Psoriasis Drugs Market Historical Market Value (US$ Mn) Analysis, 2016-2021
Figure 2: Global Psoriasis Drugs Current and Future Market Value (US$ Mn), 2022-2031 & Y-o-Y Growth Trend Analysis
Figure 3: Psoriasis Drugs Market Absolute $ Opportunity, 2022-2031
Figure 4: Global Psoriasis Drugs Market Share Analysis (%) By Product, 2022 & 2031
Figure 5: Global Psoriasis Drugs Market Y-o-Y Growth (%) By Product, 2022-2031
Figure 6: Global Psoriasis Drugs Market Attractiveness Analysis, By Product
Figure 7: Global Psoriasis Drugs Market Share Analysis (%) By Drug Class, 2022 & 2031
Figure 8: Global Psoriasis Drugs Market Y-o-Y Growth (%) By Drug Class, 2022-2031
Figure 9: Global Psoriasis Drugs Market Attractiveness Analysis, By Drug Class
Figure 10: Global Psoriasis Drugs Market Share Analysis (%) By Distribution Channel, 2022 & 2031
Figure 11: Global Psoriasis Drugs Market Y-o-Y Growth (%) By Distribution Channel, 2022-2031
Figure 12: Global Psoriasis Drugs Market Attractiveness Analysis, By Distribution Channel
Figure 13: Global Psoriasis Drugs Market Share Analysis (%) By Indication, 2022 & 2031
Figure 14: Global Psoriasis Drugs Market Y-o-Y Growth (%) By Indication, 2022-2031
Figure 15: Global Psoriasis Drugs Market Attractiveness Analysis, By Indication
Figure 16: Global Psoriasis Drugs Market Share Analysis (%) By Region, 2022 & 2031
Figure 17: Global Psoriasis Drugs Market Y-o-Y Growth (%) By Region, 2022-2031
Figure 18: Global Psoriasis Drugs Market Attractiveness Analysis, By Region
Figure 19: North America Psoriasis Drugs Market Share, By Product (2022)
Figure 20: North America Psoriasis Drugs Market Share, By Drug Class (2022)
Figure 21: North America Psoriasis Drugs Market Share, By Distribution Channel (2022)
Figure 22: North America Psoriasis Drugs Market Share, By Indication (2022)
Figure 23: North America Psoriasis Drugs Market Share, By Country (2022)
Figure 24: North America Psoriasis Drugs Market Value (US$ Mn) Analysis, 2016-2021
Figure 25: North America Psoriasis Drugs Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2031
Figure 26: North America Psoriasis Drugs Market Attractiveness Analysis, By Country
Figure 27: North America Psoriasis Drugs Market Attractiveness Analysis, By Product
Figure 28: North America Psoriasis Drugs Market Attractiveness Analysis, By Drug Class
Figure 29: North America Psoriasis Drugs Market Attractiveness Analysis, By Distribution Channel
Figure 30: North America Psoriasis Drugs Market Attractiveness Analysis, By Indication
Figure 31: Latin America Psoriasis Drugs Market Share, By Product (2022)
Figure 32: Latin America Psoriasis Drugs Market Share, By Drug Class (2022)
Figure 33: Latin America Psoriasis Drugs Market Share, By Distribution Channel (2022)
Figure 34: Latin America Psoriasis Drugs Market Share, By Indication (2022)
Figure 35: Latin America Psoriasis Drugs Market Share, By Country (2022)
Figure 36: Latin America Psoriasis Drugs Market Value (US$ Mn) Analysis, 2016-2021
Figure 37: Latin America Psoriasis Drugs Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2031
Figure 38: Latin America Psoriasis Drugs Market Attractiveness Analysis, By Country
Figure 39: Latin America Psoriasis Drugs Market Attractiveness Analysis, By Product
Figure 40: Latin America Psoriasis Drugs Market Attractiveness Analysis, By Drug Class
Figure 41: Latin America Psoriasis Drugs Market Attractiveness Analysis, By Distribution Channel
Figure 42: Latin America Psoriasis Drugs Market Attractiveness Analysis, By Indication
Figure 43: Europe Psoriasis Drugs Market Share, By Product (2022)
Figure 44: Europe Psoriasis Drugs Market Share, By Drug Class (2022)
Figure 45: Europe Psoriasis Drugs Market Share, By Distribution Channel (2022)
Figure 46: Europe Psoriasis Drugs Market Share, By Indication (2022)
Figure 47: Europe Psoriasis Drugs Market Share, By Country (2022)
Figure 48: Europe Psoriasis Drugs Market Value (US$ Mn) Analysis, 2016-2021
Figure 49: Europe Psoriasis Drugs Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2031
Figure 50: Europe Psoriasis Drugs Market Attractiveness Analysis, By Country
Figure 51: Europe Psoriasis Drugs Market Attractiveness Analysis, By Product
Figure 52: Europe Psoriasis Drugs Market Attractiveness Analysis, By Drug Class
Figure 53: Europe Psoriasis Drugs Market Attractiveness Analysis, By Distribution Channel
Figure 54: Europe Psoriasis Drugs Market Attractiveness Analysis, By Indication
Figure 55: East Asia Psoriasis Drugs Market Share, By Product (2022)
Figure 56: East Asia Psoriasis Drugs Market Share, By Drug Class (2022)
Figure 57: East Asia Psoriasis Drugs Market Share, By Distribution Channel (2022)
Figure 58: East Asia Psoriasis Drugs Market Share, By Indication (2022)
Figure 59: East Asia Psoriasis Drugs Market Share, By Country (2022)
Figure 60: East Asia Psoriasis Drugs Market Value (US$ Mn) Analysis, 2016-2021
Figure 61: East Asia Psoriasis Drugs Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2031
Figure 62: East Asia Psoriasis Drugs Market Attractiveness Analysis, By Country
Figure 63: East Asia Psoriasis Drugs Market Attractiveness Analysis, By Product
Figure 64: East Asia Psoriasis Drugs Market Attractiveness Analysis, By Drug Class
Figure 65: East Asia Psoriasis Drugs Market Attractiveness Analysis, By Distribution Channel
Figure 66: East Asia Psoriasis Drugs Market Attractiveness Analysis, By Indication
Figure 67: South Asia Psoriasis Drugs Market Share, By Product (2022)
Figure 68: South Asia Psoriasis Drugs Market Share, By Drug Class (2022)
Figure 69: South Asia Psoriasis Drugs Market Share, By Distribution Channel (2022)
Figure 70: South Asia Psoriasis Drugs Market Share, By Indication (2022)
Figure 71: South Asia Psoriasis Drugs Market Share, By Country (2022)
Figure 72: South Asia Psoriasis Drugs Market Value (US$ Mn) Analysis, 2016-2021
Figure 73: South Asia Psoriasis Drugs Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2031
Figure 74: South Asia Psoriasis Drugs Market Attractiveness Analysis, By Country
Figure 75: South Asia Psoriasis Drugs Market Attractiveness Analysis, By Product
Figure 76: South Asia Psoriasis Drugs Market Attractiveness Analysis, By Drug Class
Figure 77: South Asia Psoriasis Drugs Market Attractiveness Analysis, By Distribution Channel
Figure 78: South Asia Psoriasis Drugs Market Attractiveness Analysis, By Indication
Figure 79: Oceania Psoriasis Drugs Market Share, By Product (2022)
Figure 80: Oceania Psoriasis Drugs Market Share, By Drug Class (2022)
Figure 81: Oceania Psoriasis Drugs Market Share, By Distribution Channel (2022)
Figure 82: Oceania Psoriasis Drugs Market Share, By Indication (2022)
Figure 83: Oceania Psoriasis Drugs Market Share, By Country (2022)
Figure 84: Oceania Psoriasis Drugs Market Value (US$ Mn) Analysis, 2016-2021
Figure 85: Oceania Psoriasis Drugs Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2031
Figure 86: Oceania Psoriasis Drugs Market Attractiveness Analysis, By Country
Figure 87: Oceania Psoriasis Drugs Market Attractiveness Analysis, By Product
Figure 88: Oceania Psoriasis Drugs Market Attractiveness Analysis, By Drug Class
Figure 89: Oceania Psoriasis Drugs Market Attractiveness Analysis, By Distribution Channel
Figure 90: Oceania Psoriasis Drugs Market Attractiveness Analysis, By Indication
Figure 91: MEA Psoriasis Drugs Market Share, By Product (2022)
Figure 92: MEA Psoriasis Drugs Market Share, By Drug Class (2022)
Figure 93: MEA Psoriasis Drugs Market Share, By Distribution Channel (2022)
Figure 94: MEA Psoriasis Drugs Market Share, By Indication (2022)
Figure 95: MEA Psoriasis Drugs Market Share, By Country (2022)
Figure 96: MEA Psoriasis Drugs Market Value (US$ Mn) Analysis, 2016-2021
Figure 97: MEA Psoriasis Drugs Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2031
Figure 98: MEA Psoriasis Drugs Market Attractiveness Analysis, By Country
Figure 99: MEA Psoriasis Drugs Market Attractiveness Analysis, By Product
Figure 100: MEA Psoriasis Drugs Market Attractiveness Analysis, By Drug Class
Figure 101: MEA Psoriasis Drugs Market Attractiveness Analysis, By Distribution Channel
Figure 102: MEA Psoriasis Drugs Market Attractiveness Analysis, By Indication
Figure 103: U.S. Market Value Proportion Analysis
Figure 104: Global Vs. U.S Growth Comparison
Figure 105: U.S. Psoriasis Drugs Market Share Analysis (%) By Product, 2022 & 2031
Figure 106: U.S. Psoriasis Drugs Market Share Analysis (%) By Drug Class, 2022 & 2031
Figure 107: U.S. Psoriasis Drugs Market Share Analysis (%) By Distribution Channel, 2022 & 2031
Figure 108: U.S. Psoriasis Drugs Market Share Analysis (%) By Indication, 2022 & 2031
Figure 109: Canada Market Value Proportion Analysis
Figure 110: Global Vs. Canada Growth Comparison
Figure 111: Canada Psoriasis Drugs Market Share Analysis (%) By Product, 2022 & 2031
Figure 112: Canada Psoriasis Drugs Market Share Analysis (%) By Drug Class, 2022 & 2031
Figure 113: Canada Psoriasis Drugs Market Share Analysis (%) By Distribution Channel, 2022 & 2031
Figure 114: Canada Psoriasis Drugs Market Share Analysis (%) By Indication, 2022 & 2031
Figure 115: Brazil Market Value Proportion Analysis
Figure 116: Global Vs. Brazil Growth Comparison
Figure 117: Brazil Psoriasis Drugs Market Share Analysis (%) By Product, 2022 & 2031
Figure 118: Brazil Psoriasis Drugs Market Share Analysis (%) By Drug Class, 2022 & 2031
Figure 119: Brazil Psoriasis Drugs Market Share Analysis (%) By Distribution Channel, 2022 & 2031
Figure 120: Brazil Psoriasis Drugs Market Share Analysis (%) By Indication, 2022 & 2031
Figure 121: Mexico Market Value Proportion Analysis
Figure 122: Global Vs. Mexico Growth Comparison
Figure 123: Mexico Psoriasis Drugs Market Share Analysis (%) By Product, 2022 & 2031
Figure 124: Mexico Psoriasis Drugs Market Share Analysis (%) By Drug Class, 2022 & 2031
Figure 125: Mexico Psoriasis Drugs Market Share Analysis (%) By Distribution Channel, 2022 & 2031
Figure 126: Mexico Psoriasis Drugs Market Share Analysis (%) By Indication, 2022 & 2031
Figure 127: U.K. Market Value Proportion Analysis
Figure 128: Global Vs. U.K. Growth Comparison
Figure 129: U.K. Psoriasis Drugs Market Share Analysis (%) By Product, 2022 & 2031
Figure 130: U.K. Psoriasis Drugs Market Share Analysis (%) By Drug Class, 2022 & 2031
Figure 131: U.K. Psoriasis Drugs Market Share Analysis (%) By Distribution Channel, 2022 & 2031
Figure 132: U.K. Psoriasis Drugs Market Share Analysis (%) By Indication, 2022 & 2031
Figure 133: Germany Market Value Proportion Analysis
Figure 134: Global Vs. Germany Growth Comparison
Figure 135: Germany Psoriasis Drugs Market Share Analysis (%) By Product, 2022 & 2031
Figure 136: Germany Psoriasis Drugs Market Share Analysis (%) By Drug Class, 2022 & 2031
Figure 137: Germany Psoriasis Drugs Market Share Analysis (%) By Distribution Channel, 2022 & 2031
Figure 138: Germany Psoriasis Drugs Market Share Analysis (%) By Indication, 2022 & 2031
Figure 139: Italy Market Value Proportion Analysis
Figure 140: Global Vs. Italy Growth Comparison
Figure 141: Italy Psoriasis Drugs Market Share Analysis (%) By Product, 2022 & 2031
Figure 142: Italy Psoriasis Drugs Market Share Analysis (%) By Drug Class, 2022 & 2031
Figure 143: Italy Psoriasis Drugs Market Share Analysis (%) By Distribution Channel, 2022 & 2031
Figure 144: Italy Psoriasis Drugs Market Share Analysis (%) By Indication, 2022 & 2031
Figure 145: France Market Value Proportion Analysis
Figure 146: Global Vs. France Growth Comparison
Figure 147: France Psoriasis Drugs Market Share Analysis (%) By Product, 2022 & 2031
Figure 148: France Psoriasis Drugs Market Share Analysis (%) By Drug Class, 2022 & 2031
Figure 149: France Psoriasis Drugs Market Share Analysis (%) By Distribution Channel, 2022 & 2031
Figure 150: France Psoriasis Drugs Market Share Analysis (%) By Indication, 2022 & 2031
Figure 151: BENELUX Market Value Proportion Analysis
Figure 152: Global Vs. BENELUX Growth Comparison
Figure 153: BENELUX Psoriasis Drugs Market Share Analysis (%) By Product, 2022 & 2031
Figure 154: BENELUX Psoriasis Drugs Market Share Analysis (%) By Drug Class, 2022 & 2031
Figure 155: BENELUX Psoriasis Drugs Market Share Analysis (%) By Distribution Channel, 2022 & 2031
Figure 156: BENELUX Psoriasis Drugs Market Share Analysis (%) By Indication, 2022 & 2031
Figure 157: Spain Market Value Proportion Analysis
Figure 158: Global Vs. Spain Growth Comparison
Figure 159: Spain Psoriasis Drugs Market Share Analysis (%) By Product, 2022 & 2031
Figure 160: Spain Psoriasis Drugs Market Share Analysis (%) By Drug Class, 2022 & 2031
Figure 161: Spain Psoriasis Drugs Market Share Analysis (%) By Distribution Channel, 2022 & 2031
Figure 162: Spain Psoriasis Drugs Market Share Analysis (%) By Indication, 2022 & 2031
Figure 163: Russia Market Value Proportion Analysis
Figure 164: Global Vs. Russia Growth Comparison
Figure 165: Russia Psoriasis Drugs Market Share Analysis (%) By Product, 2022 & 2031
Figure 166: Russia Psoriasis Drugs Market Share Analysis (%) By Drug Class, 2022 & 2031
Figure 167: Russia Psoriasis Drugs Market Share Analysis (%) By Distribution Channel, 2022 & 2031
Figure 168: Russia Psoriasis Drugs Market Share Analysis (%) By Indication, 2022 & 2031
Figure 169: China Market Value Proportion Analysis
Figure 170: Global Vs. China Growth Comparison
Figure 171: China Psoriasis Drugs Market Share Analysis (%) By Product, 2022 & 2031
Figure 172: China Psoriasis Drugs Market Share Analysis (%) By Drug Class, 2022 & 2031
Figure 173: China Psoriasis Drugs Market Share Analysis (%) By Distribution Channel, 2022 & 2031
Figure 174: China Psoriasis Drugs Market Share Analysis (%) By Indication, 2022 & 2031
Figure 175: Japan Market Value Proportion Analysis
Figure 176: Global Vs. Japan Growth Comparison
Figure 177: Japan Psoriasis Drugs Market Share Analysis (%) By Product, 2022 & 2031
Figure 178: Japan Psoriasis Drugs Market Share Analysis (%) By Drug Class, 2022 & 2031
Figure 179: Japan Psoriasis Drugs Market Share Analysis (%) By Distribution Channel, 2022 & 2031
Figure 180: Japan Psoriasis Drugs Market Share Analysis (%) By Indication, 2022 & 2031
Figure 181: South Korea Market Value Proportion Analysis
Figure 182: Global Vs. South Korea Growth Comparison
Figure 183: South Korea Psoriasis Drugs Market Share Analysis (%) By Product, 2022 & 2031
Figure 184: South Korea Psoriasis Drugs Market Share Analysis (%) By Drug Class, 2022 & 2031
Figure 185: South Korea Psoriasis Drugs Market Share Analysis (%) By Distribution Channel, 2022 & 2031
Figure 186: South Korea Psoriasis Drugs Market Share Analysis (%) By Indication, 2022 & 2031
Figure 187: India Market Value Proportion Analysis
Figure 188: Global Vs. India Growth Comparison
Figure 189: India Psoriasis Drugs Market Share Analysis (%) By Product, 2022 & 2031
Figure 190: India Psoriasis Drugs Market Share Analysis (%) By Drug Class, 2022 & 2031
Figure 191: India Psoriasis Drugs Market Share Analysis (%) By Distribution Channel, 2022 & 2031
Figure 192: India Psoriasis Drugs Market Share Analysis (%) By Indication, 2022 & 2031
Figure 193: Thailand Market Value Proportion Analysis
Figure 194: Global Vs. Thailand Growth Comparison
Figure 195: Thailand Psoriasis Drugs Market Share Analysis (%) By Product, 2022 & 2031
Figure 196: Thailand Psoriasis Drugs Market Share Analysis (%) By Drug Class, 2022 & 2031
Figure 197: Thailand Psoriasis Drugs Market Share Analysis (%) By Distribution Channel, 2022 & 2031
Figure 198: Thailand Psoriasis Drugs Market Share Analysis (%) By Indication, 2022 & 2031
Figure 199: Malaysia Market Value Proportion Analysis
Figure 200: Global Vs. Malaysia Growth Comparison
Figure 201: Malaysia Psoriasis Drugs Market Share Analysis (%) By Product, 2022 & 2031
Figure 202: Malaysia Psoriasis Drugs Market Share Analysis (%) By Drug Class, 2022 & 2031
Figure 203: Malaysia Psoriasis Drugs Market Share Analysis (%) By Distribution Channel, 2022 & 2031
Figure 204: Malaysia Psoriasis Drugs Market Share Analysis (%) By Indication, 2022 & 2031
Figure 205: Indonesia Market Value Proportion Analysis
Figure 206: Global Vs. Indonesia Growth Comparison
Figure 207: Indonesia Psoriasis Drugs Market Share Analysis (%) By Product, 2022 & 2031
Figure 208: Indonesia Psoriasis Drugs Market Share Analysis (%) By Drug Class, 2022 & 2031
Figure 209: Indonesia Psoriasis Drugs Market Share Analysis (%) By Distribution Channel, 2022 & 2031
Figure 210: Indonesia Psoriasis Drugs Market Share Analysis (%) By Indication, 2022 & 2031
Figure 211: Australia Market Value Proportion Analysis
Figure 212: Global Vs. Australia Growth Comparison
Figure 213: Australia Psoriasis Drugs Market Share Analysis (%) By Product, 2022 & 2031
Figure 214: Australia Psoriasis Drugs Market Share Analysis (%) By Drug Class, 2022 & 2031
Figure 215: Australia Psoriasis Drugs Market Share Analysis (%) By Distribution Channel, 2022 & 2031
Figure 216: Australia Psoriasis Drugs Market Share Analysis (%) By Indication, 2022 & 2031
Figure 217: New Zealand Market Value Proportion Analysis
Figure 218: Global Vs. New Zealand Growth Comparison
Figure 219: New Zealand Psoriasis Drugs Market Share Analysis (%) By Product, 2022 & 2031
Figure 220: New Zealand Psoriasis Drugs Market Share Analysis (%) By Drug Class, 2022 & 2031
Figure 221: New Zealand Psoriasis Drugs Market Share Analysis (%) By Distribution Channel, 2022 & 2031
Figure 222: New Zealand Psoriasis Drugs Market Share Analysis (%) By Indication, 2022 & 2031
Figure 223: GCC Countries Market Value Proportion Analysis
Figure 224: Global Vs. GCC Countries Growth Comparison
Figure 225: GCC Countries Psoriasis Drugs Market Share Analysis (%) By Product, 2022 & 2031
Figure 226: GCC Countries Psoriasis Drugs Market Share Analysis (%) By Drug Class, 2022 & 2031
Figure 227: GCC Countries Psoriasis Drugs Market Share Analysis (%) By Distribution Channel, 2022 & 2031
Figure 228: GCC Countries Psoriasis Drugs Market Share Analysis (%) By Indication, 2022 & 2031
Figure 229: South Africa Market Value Proportion Analysis
Figure 230: Global Vs. South Africa Growth Comparison
Figure 231: South Africa Psoriasis Drugs Market Share Analysis (%) By Product, 2022 & 2031
Figure 232: South Africa Psoriasis Drugs Market Share Analysis (%) By Drug Class, 2022 & 2031
Figure 233: South Africa Psoriasis Drugs Market Share Analysis (%) By Distribution Channel, 2022 & 2031
Figure 234: South Africa Psoriasis Drugs Market Share Analysis (%) By Indication, 2022 & 2031
